Idaho's state health plan and GLP-1s
Four pages and a date. Idaho's Office of Group Insurance wrote to every health plan participant to say that coverage for weight-loss medication would stop on November 1, 2025 — Wegovy, Saxenda, Zepbound, and anything else prescribed mainly to lose weight. Diabetes prescriptions were untouched. Unusually, the memorandum does not stop at the decision: it names the money saved, confirms that school districts are included, tells members they may drop the plan because of it, and lists where to buy the drugs yourself.
What changed, and what the document says
The date coverage stopped
Not coveredOne sentence, one date, and no carve-out for members already partway through a course.
“Effective November 1, 2025, coverage for all medications prescribed for weight loss will be discontinued.”
State of Idaho – Office of Group Insurance — September 4, 2025
What survived the cut
Conditions applyThe line is drawn at the indication, not the drug, so the same molecule can still be paid for under a different diagnosis.
“This change does not impact coverage for GLP-1 medications when prescribed for the treatment of diabetes.”
State of Idaho – Office of Group Insurance — September 4, 2025
How wide the wording goes
Not coveredThe list of affected drugs ends with a catch-all that closes the off-label route as well as the labeled one.
“Any GLP-1 medication prescribed primarily for weight loss, regardless of FDA approval or off-label use”
State of Idaho – Office of Group Insurance — September 4, 2025
The number the office put on it
ContextVery few benefit notices quantify their own saving. This one answers the question in a frequently-asked-questions block.
“Yes, the increase will be reduced by approximately $30–50 million annually, resulting in savings for both the employer and employee shares.”
State of Idaho – Office of Group Insurance — September 4, 2025
Who it reaches
Not coveredAsked directly whether school districts were included, the office answered in three words.
“Yes, it impacts all members.”
State of Idaho – Office of Group Insurance — September 4, 2025
Where the memorandum sends you instead
Conditions applyIt recommends going direct to the manufacturers and then, to its credit, says what that means for the bill.
“However, the member is still responsible for the full cost of the medication.”
State of Idaho – Office of Group Insurance — September 4, 2025
The drug list still prints all three
Conditions applyMonths after the cut, the plan's published six-tier list still carries Wegovy, Zepbound and Saxenda, each marked with the indicator the same list defines below. The list alone will not tell you the answer; the memorandum will.
“Drugs with a “+” indicator next to them on the Drug List have group-specific coverage.”
Regence BlueShield of Idaho, published by the State of Idaho Office of Group Insurance — Six Tier Drug List Standard March 2026
Which of these companies serve Idaho?
Of the 257 companies we grade, 25 publish a list of the states they are licensed in. We checked 229 more and found no such list on any page we read; 3 we have not checked either way.
17 of those lists name Idaho: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Memorandum — Policy Update – Elimination of Coverage for Weight Loss Medications, Including GLP-1s for Weight Loss — State of Idaho – Office of Group Insurance. Date line in the memorandum header — one day earlier than the date in its own file name: September 4, 2025.
- Six Tier Drug List (Large Group) — Regence BlueShield of Idaho, published by the State of Idaho Office of Group Insurance. Running footer on every page of the list; the file name says FY26-27 and the pages say March 2026: Six Tier Drug List Standard March 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. None of the 3 rows below carries both a medication price and a monthly fee we could capture, so no figure here is a sum. Each cell says what its number covers and what we could not confirm, and every number was read on the seller's own page.
NovoCare Pharmacy, LillyDirect and Harbor pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | NovoCare Pharmacy | $149a month, medication onlybrand Wegovy tablets 1.5 mgMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Self-pay. One month is one bottle of 30 tablets.The lowest of the 9 medication prices we captured here | The memorandum names this counter by name as somewhere to go once the plan stops paying — here is what it actually charges, dose by dose. | See its prices at NovoCare Pharmacy (opens in a new tab)Pays us nothing |
| BMinor gap | LillyDirect | $149a month, medication onlybrand Foundayo 0.8 mg and 2.5 mgMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.The 2.5 mg rate is marked as temporarily reduced through December 31, 2026.The lowest of the 8 medication prices we captured here | The other manufacturer counter the memorandum names, selling tirzepatide direct; check the per-strength prices before treating it as the cheap route. | See its prices at LillyDirect (opens in a new tab)Pays us nothing |
| CCaveat | Harbor | $89a month, medication onlyCompounded semaglutide, published floorMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.A from-price. The page promises flat pricing across doses but names no plan term.The lowest of the 3 medication prices we captured here | Compounded semaglutide from $89 and tirzepatide from $149, with three of its own surfaces quoting three different numbers — worth knowing when the full cost is yours. | See its prices at Harbor (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.